A Critique of The Lancet COVID-19 Commission

A Critique of The Lancet COVID-19 Commission

Opinion | The Lancet recently released its long-awaited COVID-19 commission report. The report well reflects the current state of public health science and addresses the business needs of The Lancet. It may have been naïve to expect further, but health is an important area and should be taken more seriously. The level of obfuscation of evidence, misrepresentation of […]

The Naked Absurdity of Global Public Health

The Naked Absurdity of Global Public Health

Opinion | Something is fundamentally wrong with global public health. More accurately, something is fundamentally wrong with the mindset of global health professionals, particularly those in positions of leadership. It has become normal to speak, repeat, and defend complete absurdity, as if illusions and fantasies are real. There are no sanctions for operating in this […]

Study Reveals Much Higher Risk for Serious Adverse Events With mRNA COVID Shots in Clinical Trials

Study Reveals Much Higher Risk for Serious Adverse Events With mRNA COVID Shots in Clinical Trials

A new study published in the journal Vaccine revealed there was a much higher risk of serious adverse events of special interest for randomized clinical trial participants who received a messenger RNA (mRNA) COVID-19 biologic when compared to participants, who received a placebo for both the Pfizer/BioNTech mRNA BNT162b2 (also known as “Comirnaty”) COVID shot […]

Tanzanian Government Skeptical About Safety of COVID-19 Vaccines

Tanzanian Government Skeptical About Safety of COVID-19 Vaccines

On Feb 2, 2021, Tanzania’s health minister, Dorothy Gwajima, announced that her country has no plans in place to recommend widespread use of COVID-19 vaccines in the African country.1 The announcement came a few days after Tanzania’s President John Magufuli expressed concern about the safety and effectiveness of COVID-19 vaccines developed and manufactured in Western […]

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]

Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells

Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells

Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]

COVID-19 Meltdown and Pharma’s Big Money Win

COVID-19 Meltdown and Pharma’s Big Money Win

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Moderna to Use New mRNA Technology to Develop Coronavirus Vaccine

Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]